Literature DB >> 9338024

Primary infection by type 1 human immunodeficiency virus: diagnosis and prognosis.

P Vanhems1, R Beaulieu.   

Abstract

Primary infection by type 1 human immunodeficiency virus (HIV) is symptomatic in about 70% of cases. The acute illness is a mononucleosis-like syndrome with characteristics such as mucosal ulcerations. The duration and severity of the symptoms appear to be related to the prognosis. After reviewing the most frequent signs and symptoms of primary HIV infection, we report different prognostic studies which examined the association between the acute illness and the progression of HIV disease.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9338024      PMCID： PMC2431388          DOI： 10.1136/pgmj.73.861.403

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  31 in total

1.  Susceptibility to AIDS progression appears early in HIV infection.

Authors:  M T Schechter; K J Craib; T N Le; J S Montaner; B Douglas; P Sestak; B Willoughby; M V O'Shaughnessy
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

Review 2.  Resistance, drug failure, and disease progression.

Authors:  D D Richman
Journal:  AIDS Res Hum Retroviruses       Date:  1994-08       Impact factor: 2.205

3.  A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5.

Authors:  S Itescu; L J Brancato; J Buxbaum; P K Gregersen; C C Rizk; T S Croxson; G E Solomon; R Winchester
Journal:  Ann Intern Med       Date:  1990-01-01       Impact factor: 25.391

4.  Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.

Authors:  A R Lifson; S P Buchbinder; H W Sheppard; A C Mawle; J C Wilber; M Stanley; C E Hart; N A Hessol; S D Holmberg
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

Review 5.  New concepts in the immunopathogenesis of HIV infection.

Authors:  G Pantaleo; A S Fauci
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Authors:  S Kinloch-De Loës; B J Hirschel; B Hoen; D A Cooper; B Tindall; A Carr; J H Saurat; N Clumeck; A Lazzarin; L Mathiesen
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

7.  Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time.

Authors:  H Farzadegan; J S Chmiel; N Odaka; L Ward; L Poggensee; A Saah; J P Phair
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

8.  AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters.

Authors:  R J Biggar
Journal:  AIDS       Date:  1990-11       Impact factor: 4.177

9.  Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 x 10(6)/l, AIDS, and death from AIDS?

Authors:  S Lindbäck; C Broström; A Karlsson; H Gaines
Journal:  BMJ       Date:  1994-12-10

10.  A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study.

Authors:  R A Kaslow; R Duquesnoy; M VanRaden; L Kingsley; M Marrari; H Friedman; S Su; A J Saah; R Detels; J Phair
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321
View more
  1 in total

1.  Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin.

Authors:  Marco Gelpi; Hans J Hartling; Kristina Thorsteinsson; Jan Gerstoft; Henrik Ullum; Susanne D Nielsen
Journal:  BMC Infect Dis       Date:  2016-10-21       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.